VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Relmada Therapeutics, Inc. (RLMD) Total Return Calculator with Dividends Reinvested

Relmada Therapeutics, Inc.

Popular:

The total return for Relmada Therapeutics, Inc. (RLMD) stock is +2060.51% over the past 12 months. So far it's up 70.02% this year. The 5-year total return is +2.20%, meaning $10,000 invested in RLMD stock 5 years ago would be worth $10,220 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in RLMD 1 year ago, it would be worth $204,514 today — you'd have gained $194,514.

With Dividends Reinvested$204,514+1945.14%

Price Only (No DRIP)$204,514+1945.14%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in RLMD

1Y$216,051+$206,051 (+2060.5%)2060.5% CAGR

3Y$83,955+$73,955 (+739.5%)103.2% CAGR

5Y$10,220+$220 (+2.2%)0.4% CAGR

10Y$41,278+$31,278 (+312.8%)15.2% CAGR

15Y$6,192-$3,808 (-38.1%)-3.1% CAGR

20Y$6,192-$3,808 (-38.1%)-2.4% CAGR

30Y$6,192-$3,808 (-38.1%)-1.6% CAGR

Relmada Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading RLMD total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+70.02%	—	+70.02%	—	$17,002
1Y	+2060.51%	2060.51%	+2060.51%	—	$216,051
3Y	+739.55%	103.24%	+739.55%	—	$83,955
5Y	+2.20%	0.44%	+2.20%	—	$10,220
10Y	+312.78%	15.23%	+312.78%	—	$41,278
15Y	-38.08%	-3.15%	-38.08%	—	$6,192
20Y	-38.08%	-2.37%	-38.08%	—	$6,192
30Y	-38.08%	-1.59%	-38.08%	—	$6,192

Risk & Highlights

Best Year+973.09%2025

Worst Year-84.13%2015

Max Drawdown-35.78%2025-06-06 → 2025-06-25 · Recovered 2025-08-29

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+4.35%	+4.35%	—	+0.41%	+3.9pp
2025	+973.09%	+973.09%	—	+16.64%	+956.5pp
2024	-52.29%	-52.29%	—	+24.00%	-76.3pp
2023	+22.62%	+22.62%	—	+24.81%	-2.2pp
2022	-81.55%	-81.55%	—	-19.95%	-61.6pp

RLMD outperformed the S&P 500 by 2030.14pp over the past year (+2060.51% vs +30.37%).

Loading summary...

RLMD Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
RLMDRelmada Therapeutics, Inc.	$545M	+10.1%	+70.0%	+2060.5%	—	+739.5%	+2.2%	+312.8%
AXSMAxsome Therapeutics, Inc.	$11.3B	+30.4%	+23.2%	+98.5%	—	+183.2%	+286.4%	+1886.5%
ALTOAlto Ingredients, Inc.	$351M	+2.9%	+70.7%	+427.8%	—	+233.8%	-21.2%	+6.8%
INVAInnoviva, Inc.	$1.9B	-2.1%	+14.7%	+21.7%	—	+95.2%	+94.4%	+94.9%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
INTRInter & Co, Inc.	$2.9B	-13.5%	-19.4%	+0.9%	+1.7pp	+268.3%	+98.9%	+98.9%
SAVACassava Sciences, Inc.	$94M	—	-6.5%	+25.3%	—	-40.8%	-67.0%	-19.5%
NRXPNRx Pharmaceuticals, Inc.	$85M	+37.2%	+16.8%	+55.3%	—	-50.6%	-99.1%	-96.8%
MNMDMind Medicine (MindMed) Inc.	$2.0B	—	+51.7%	+214.0%	—	+510.3%	-57.9%	+512.1%
IQVIQVIA Holdings Inc.	$30.3B	+4.7%	-20.7%	+16.5%	—	-5.9%	-23.8%	+166.5%

Compare:RLMD vs AXSM RLMD vs ALTO RLMD vs INVA RLMD vs AXSM vs ALTO

About RLMD Dividend Returns

Relmada Therapeutics, Inc. (RLMD) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of RLMD over the past year?

Relmada Therapeutics, Inc. (RLMD) delivered a return of 2060.51% over the past year. Since RLMD does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in RLMD be worth today?

A $10,000 investment in Relmada Therapeutics, Inc. one year ago would be worth $216,051 today, representing a gain of $206,051.

Q3Does RLMD pay dividends?

Relmada Therapeutics, Inc. (RLMD) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RLMD, the total return equals the price-only return.

Q4Did RLMD beat the S&P 500?

Yes, Relmada Therapeutics, Inc. (RLMD) outperformed the S&P 500 by 2030.14 percentage points over the past year. RLMD delivered a total return of 2060.51%, compared to the S&P 500's 30.37%. This 2030.14pp alpha means investors in RLMD earned more than a passive S&P 500 index fund.

Q5What is RLMD's worst drawdown?

Relmada Therapeutics, Inc. (RLMD) experienced a maximum drawdown of -35.78% over the past year, declining from its peak on 2025-06-06 to its trough on 2025-06-25. The stock recovered to its prior peak by 2025-08-29. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is RLMD's long-term total return over 10, 20, or 30 years?

Here are Relmada Therapeutics, Inc. (RLMD)'s long-term returns with dividends reinvested. Over 10 years, the total return is 312.8% (15.2% CAGR) — $10,000 would have grown to $41,278. Over 20 years: -38.1% total return (-2.4% CAGR) — $10,000 → $6,192. Over 30 years: -38.1% total return (-1.6% CAGR) — $10,000 → $6,192. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was RLMD's best and worst year?

Relmada Therapeutics, Inc.'s best calendar year was 2025 with a total return of 973.1%. Its worst year was 2015 with a total return of -84.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 1057.2 percentage points.